These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 35737447)

  • 1. Integrating multi-omics data reveals function and therapeutic potential of deubiquitinating enzymes.
    Doherty LM; Mills CE; Boswell SA; Liu X; Hoyt CT; Gyori B; Buhrlage SJ; Sorger PK
    Elife; 2022 Jun; 11():. PubMed ID: 35737447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissenting degradation: Deubiquitinases in cell cycle and cancer.
    Bonacci T; Emanuele MJ
    Semin Cancer Biol; 2020 Dec; 67(Pt 2):145-158. PubMed ID: 32201366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deubiquitinating enzymes regulate PARK2-mediated mitophagy.
    Wang Y; Serricchio M; Jauregui M; Shanbhag R; Stoltz T; Di Paolo CT; Kim PK; McQuibban GA
    Autophagy; 2015 Apr; 11(4):595-606. PubMed ID: 25915564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deubiquitinating enzymes (DUBs): Regulation, homeostasis, and oxidative stress response.
    Snyder NA; Silva GM
    J Biol Chem; 2021 Sep; 297(3):101077. PubMed ID: 34391779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deubiquitinating enzymes as cancer biomarkers: new therapeutic opportunities?
    Poondla N; Chandrasekaran AP; Kim KS; Ramakrishna S
    BMB Rep; 2019 Mar; 52(3):181-189. PubMed ID: 30760385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics-Based Identification of DUB Substrates Using Selective Inhibitors.
    Bushman JW; Donovan KA; Schauer NJ; Liu X; Hu W; Varca AC; Buhrlage SJ; Fischer ES
    Cell Chem Biol; 2021 Jan; 28(1):78-87.e3. PubMed ID: 33007217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. USP32 confers cancer cell resistance to YM155 via promoting ER-associated degradation of solute carrier protein SLC35F2.
    Chandrasekaran AP; Kaushal K; Park CH; Kim KS; Ramakrishna S
    Theranostics; 2021; 11(20):9752-9771. PubMed ID: 34815782
    [No Abstract]   [Full Text] [Related]  

  • 8. The equilibrium of tumor suppression: DUBs as active regulators of PTEN.
    Christine A; Park MK; Song SJ; Song MS
    Exp Mol Med; 2022 Nov; 54(11):1814-1821. PubMed ID: 36385557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A ubiquitinome analysis to study the functional roles of the proteasome associated deubiquitinating enzymes USP14 and UCH37.
    van der Wal L; Bezstarosti K; Demmers JAA
    J Proteomics; 2022 Jun; 262():104592. PubMed ID: 35489684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the Proteasome-Associated Deubiquitinating Enzyme USP14 Impairs Melanoma Cell Survival and Overcomes Resistance to MAPK-Targeting Therapies.
    Didier R; Mallavialle A; Ben Jouira R; Domdom MA; Tichet M; Auberger P; Luciano F; Ohanna M; Tartare-Deckert S; Deckert M
    Mol Cancer Ther; 2018 Jul; 17(7):1416-1429. PubMed ID: 29703842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Mechanisms of DUBs Regulation in Signaling and Disease.
    Li Y; Reverter D
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular Assays for Dynamic Quantification of Deubiquitinase Activity and Inhibition.
    Moghadasi SA; Moraes SN; Harris RS
    J Mol Biol; 2023 Dec; 435(23):168316. PubMed ID: 37858708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein-linked ubiquitin chain structure restricts activity of deubiquitinating enzymes.
    Schaefer JB; Morgan DO
    J Biol Chem; 2011 Dec; 286(52):45186-96. PubMed ID: 22072716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A balance of deubiquitinating enzymes controls cell cycle entry.
    Mapa CE; Arsenault HE; Conti MM; Poti KE; Benanti JA
    Mol Biol Cell; 2018 Nov; 29(23):2821-2834. PubMed ID: 30207830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational and biochemical studies of isothiocyanates as inhibitors of proteasomal cysteine deubiquitinases in human cancer cells.
    Ahmed ZSO; Li X; Li F; Cheaito HA; Patel K; Mosallam EM; Elbargeesy GAEH; Dou QP
    J Cell Biochem; 2018 Nov; 119(11):9006-9016. PubMed ID: 30015387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The de novo synthesis of ubiquitin: identification of deubiquitinases acting on ubiquitin precursors.
    Grou CP; Pinto MP; Mendes AV; Domingues P; Azevedo JE
    Sci Rep; 2015 Aug; 5():12836. PubMed ID: 26235645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitin-specific peptidase 7 (USP7) and USP10 mediate deubiquitination of human NHE3 regulating its expression and activity.
    Han Y; Yun CC
    FASEB J; 2020 Dec; 34(12):16476-16488. PubMed ID: 33095475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UL36 Encoded by Marek's Disease Virus Exhibits Linkage-Specific Deubiquitinase Activity.
    Lin J; Ai Y; Zhou H; Lv Y; Wang M; Xu J; Yu C; Zhang H; Wang M
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32150874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity profiling of deubiquitylases against endogenously generated ubiquitin-protein conjugates.
    Rossio V; Paulo JA; Liu X; Gygi SP; King RW
    Cell Chem Biol; 2024 Jul; 31(7):1349-1362.e5. PubMed ID: 38810651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precise control of mitophagy through ubiquitin proteasome system and deubiquitin proteases and their dysfunction in Parkinson's disease.
    Park GH; Park JH; Chung KC
    BMB Rep; 2021 Dec; 54(12):592-600. PubMed ID: 34674795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.